loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 21992 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Pfizer Inc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 PF PRISM CV (3)

    filter

    01 TABLET, EXTENDED RELEASE;ORAL (3)

    filter

    01 RX (3)

    filter

    01 PRISTIQ (3)

    filter

    01 Yes (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DESVENLAFAXINE SUCCINATE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, EXTENDED R...
    EQ 100MG BASE
    2008-02-29
    21992
    PRISTIQ
    RX
    Yes
    AB
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DESVENLAFAXINE SUCCINATE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, EXTENDED R...
    EQ 25MG BASE
    2014-08-20
    21992
    PRISTIQ
    RX
    Yes
    AB
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DESVENLAFAXINE SUCCINATE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, EXTENDED R...
    EQ 50MG BASE
    2008-02-29
    21992
    PRISTIQ
    RX
    Yes
    AB
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 21992

    Looking for FDA Orange Book APPLICATION 21992 3

    19

    Pfizer Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is DESVENLAFAXINE SUCCINATE, with a corresponding application number 21992.

    Regulatory Information RX

    With a dosage strength EQ 100MG BASE

    Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

    Reference Listed Drug Yes

    Approved since 2008-02-29

    Therapeutic Equivalence (TE) Code AB

    18

    Pfizer Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is DESVENLAFAXINE SUCCINATE, with a corresponding application number 21992.

    Regulatory Information RX

    With a dosage strength EQ 25MG BASE

    Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

    Reference Listed Drug Yes

    Approved since 2014-08-20

    Therapeutic Equivalence (TE) Code AB

    17

    Pfizer Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is DESVENLAFAXINE SUCCINATE, with a corresponding application number 21992.

    Regulatory Information RX

    With a dosage strength EQ 50MG BASE

    Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

    Reference Listed Drug Yes

    Approved since 2008-02-29

    Therapeutic Equivalence (TE) Code AB

    Post Enquiry
    POST ENQUIRY